维普中文期刊产品整合服务
131篇 您的检索式:作者名="Tubach"
    题名 作者 年代 出处 被引量
1Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy:The three-year prospective french research axed on tolerance of biotherapies registry显示文摘Tubach F Salmon D Ravaud P etal 2009Arthritis Rheum2009,60,7:1
2Predictive factors of early postoperative urinary retention in the postanesthesia care unit 显示文摘Keita H Diouf E Tubach F 2005Anesthesia and Analgesia2005,101,2:1
3Use of procah:i- tonin to reduce patients' exposure to antibiotics in inten- sive care units(PRORATA trial): a muhicentre randomised controlled trial显示文摘Bouadma L Luyt CE Tubach F 2010Lancet2010,375,9713:1
4Use of procalcitonin to reduce pa- tients' exposure to antibioties in intensive care units(PRORATA trial): a multicentre randomised controlled trial 显示文摘Bouadma L Luyt CE Tubach F 2010Lancet2010,375,:1
5Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy 显示文摘TUBACH F SALMON D RAVAUD P 2009Arthritis Rheum2009,60,7:1
6Use of procalcitonin toreduce patients' exposure to antibiotics in intensive care units(PRORATA trial)? amulticentre randomised controlled trial显示文摘Bouadma L Luyt CE Tubach F 2010Lancet2010,375,:1
7Use of procalci- tonin to reduce patients' exposure to antibiotics in inten- sive care units ( PRORATA trial) : a multicentre random- ised controlled trial显示文摘Bouadma L Luyt CE Tubach F 2010Lancet2010,,9713:1
8Use of procalcitonin to reduce patients'exposure to antibiotics in intensive care units(PRORATA trial):a multicentre randomised controlled trial显示文摘Bouadma L Luyt CE Tubach F 2010The Lancent2010,375,9713:1
9Drug specific risk of non-tuberculosis opportunistic infections in pa- tients receiving anti-TNF therapy reported to the 3-year pro- spective French RATIO registry显示文摘Salmon-Ceron D Tubach F Lortholary O 2011Ann Rheum Dis2011,70,4:1
10Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial 1: a multi centre randomised controlled trial 显示文摘Bouadma L Luyt CE Tubach F 2010Lancet2010,375,9713:1
11Risk of tuberculosis is higher with anti tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French research axed on tolerance of biotherapies registry显示文摘Tubach F Salmon D Ravaud P etal 2009Arthritis Rheum2009,60,7:1
12Use of procalcitonin to reduce patients'exposure to antibiotics in intensive care units(PRORATA trial):a multicent rerandomised controlled trial显示文摘Bouadma L Luyt CE Tubach F 2010Lancet2010,375,9713:1
13Use of procalcitonin to re- duce patients'exposure to antibiotics in intensive care units(PRORA- TA trial) : amuhieentre randomised controlledtrial 显示文摘Bouadma L Luyt CE Tubach F 2010Lancet2010,375,9713:1
14Use of procalcitonin to shorten ICU patients' exposure to antibiotics: the randomized controlled PRORATA trail显示文摘Bouadma L Luyt C E Tubach F 2010Lancet2010,375,9713:1
15Use of procalcitonin to reduce patients't exposure to antibiotics in intensive care units (PRORATA trid):a multicentre randomised controlled trial显示文摘Bouadma L Luyt CE Tubach F 0,,9713:1
16Use of procalcitonin to reduce patients'expo- sure to antibiotics in intensive care unit ( PRO- RATA triM): A multicentre randomized con- trolled trial显示文摘Bouadma Luyt CE Tubach F 2010Lancet2010,,375:1
17Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial):a multicentre randomised controlled trial显示文摘Bouadma L Luyt CE Tubach F 0,,9713:1
18Use of procalcitoninto reduce patients' exposure to antibiotics in intensive care units(PRORATA trial) :a multicentre randomised controlled trial显示文摘BOUADMA L LUYT C E TUBACH F 2010Lancet2010,375,9713:1
19Use of procalcitonin to re- duce patients' exposure to antibiotics in intensive care units ( PRO- RATA trial) : a multicentre randomised controlled trial 显示文摘Bouadma L Luyt C E Tubach F 2010Lan- cet2010,375,9713:1
20Predictive factors of early postop- erative urinary retention in the postanesthesia care unit 显示文摘Keita H Diouf E Tubach F 2005Anesth Analg2005,101,2:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费